GHK-Cu peptide is a copper-binding tripeptide complex discussed in skin care, wound healing, collagen biology, hair research, and anti-aging conversations
Negative symptoms include reduced tactile and thermal sensations, numbness, hypoesthesia, or anaesthesia [12]
GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
Most clinicians consider tirzepatide 6-12 months after gastric sleeve surgery once post-surgical weight loss has stabilized, though timing should be individualized based on your metabolic response, nutritional status, and clinical needs